Quratis

Quratis FCF per Share

The Free Cash Flow per Share of Quratis (348080.KQ) as of Oct 15, 2026 is -1,192.33 KRW. In the previous year, Free Cash Flow per Share was -2,091.76 KRW — a change of -43.00% (higher).

FCF per Share

-1,192.33KRW

YoY

-43.00%

Last updated:

Free Cash Flow per Share of Quratis is 2025 -1,192.33 KRW. Free Cash Flow per Share of Quratis was 2024 -2,091.76 KRW. It decreases by -43.00% higher compared to the previous year.

The Quratis FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2020
-1,335.58 KRW
Jan 1, 2021
-1,042.75 KRW
Jan 1, 2022
-5,191.36 KRW
Jan 1, 2023
-3,854.19 KRW
Jan 1, 2024
-2,091.76 KRW
Jan 1, 2025
-1,192.33 KRW
The Quratis FCF per Share history
YEARFCF per ShareYoY
-1,192.33KRW-43.00%
-2,091.76KRW-45.73%
-3,854.19KRW-25.76%
-5,191.36KRW+397.85%
-1,042.75KRW-21.93%
-1,335.58KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Quratis Stock analysis

What does Quratis do? Quratis Inc is a biotechnology company based in Seoul, South Korea, operating within the Health Care sector. The company went public on June 15, 2023, with its stock listed under the ticker 348080.KQ and ISIN KR734808080003. Quratis focuses on research and development in the pharmaceutical industry, specifically developing medicine and pharmaceutical products. The company is involved in the manufacture and sale of vaccines and peptide nucleic acid complexes. It also provides Cell Penetrating Peptide (CPP) platform services. Quratis is engaged in the development and research of vaccines, including tuberculosis vaccines for adults and adolescents and COVID-19 vaccines. The company has 91 employees and maintains a website at http://quratis.com/. Quratis operates in the biotechnology industry, emphasizing innovation in vaccine development and pharmaceutical research. Its headquarters are located in Seoul, South Korea, and it is active in the development of novel therapeutic solutions for global health challenges. The company's activities span from research to commercialization, with a focus on advancing medical treatments through biotechnology. Quratis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quratis stock

Free Cash Flow per Share of Quratis is -1,192.33 KRW in 2025.

Free Cash Flow per Share of Quratis changed from -2,091.76 KRW to -1,192.33 KRW, representing a -43.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Quratis since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Quratis

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Quratis